This narrative review summarizes current evidence on the pathogenesis, diagnosis, and long term management of pediatric IBS, with emphasis on gut brain interactions, psychosocial factors, recent pediatric guidelines, and pharmacological and non-pharmacological interventions.
Abstract
Background
Irritable bowel syndrome (IBS) is a chronic disorder of gut brain interaction in children associated with recurrent abdominal pain, altered bowel habits, psychological comorbidities, impaired daily functioning, and reduced quality of life.
Aim
This narrative review summarizes current evidence on the pathogenesis, diagnosis, and long term management of pediatric IBS, with emphasis on gut brain interactions, psychosocial factors, recent pediatric guidelines, and pharmacological and non-pharmacological interventions.
Materials and Methods
PubMed, Embase, Cochrane Library, and Google Scholar were searched for English language publications from 2010 to 2026. The final search was conducted on June 15, 2026. Fifty studies and guidelines were included in the descriptive synthesis.
Results
Pediatric IBS has a multifactorial pathogenesis involving disturbances in gut brain communication, visceral hypersensitivity, post infectious mechanisms, alterations in the intestinal microbiota, and psychosocial factors. Diagnosis relies on symptom-based criteria, clinical assessment, and evaluation for alarm features; routine extensive testing is discouraged when alarm features are absent. Management should be individualized and may include education of the child and family, dietary measures, psychological interventions, and symptom directed pharmacotherapy. Cognitive behavioural therapy and gut directed hypnotherapy may reduce symptoms and psychological distress in selected children. Evidence for dietary and pharmacological interventions remains heterogeneous, and microbiome profiles are not established diagnostic biomarkers for routine clinical use.
Conclusions
Pediatric IBS should be diagnosed clinically and managed according to predominant symptoms, disease severity, psychological comorbidities, and daily functioning. Further pediatric studies are needed to clarify the effectiveness, safety, duration, and optimal sequence of interventions.
BACKGROUND
Irritable bowel syndrome (IBS) is the most common functional gastrointestinal disorder. Its pathophysiology remains incompletely understood, and no objective diagnostic markers are currently available. Diagnosis is based on the Rome IV criteria, which rely exclusively on gastrointestinal symptoms and may be...
M. Gros, B. Gros-Bañeres, J. Mesonero et al.· Semergen· 0 citations
The Rome V Criteria, published in 2026, updates the scientific and clinical understanding of irritable bowel syndrome (IBS). It redefines IBS from a “functional disorder” to a “gut-brain interaction disorder,” emphasizing biological underpinnings. Recognized pathophysiological mechanisms include impaired motility, alte...
Tatiana B. Topchii, M. Ardatskaya, L. N. Maslovskii et al.· Consilium Medicum· 0 citations
Advances in diagnostic approaches, the understanding of prevalence and pathophysiology, and growing evidence for both pharmacologic and nonpharmacologic therapies for AP-DGBI may improve future management may improve future management.
Lily Barash, Carmen Lindmoen, Rachel E. Borlack· Current opinion in pediatric...· 0 citations
Background: Irritable Bowel Syndrome (IBS) is a functional gastrointestinal condition that is very common, relapses frequently, and severely lowers a patient's quality of life. IBS is still a treatment issue in contemporary gastroenterology. It is characterized by stomach pain, bloating, and changed bowel habits withou...
Faiyaz Ahmad, V. Singh, Amreen Fatima et al.· Journal of Drug Delivery and...· 0 citations
The evolving understanding of FD supports a shift from empirical symptom-based treatment toward individualized, mechanism-informed care, and emerging approaches targeting the duodenal microenvironment, epithelial barrier, gut microbiota, and gut–brain axis are promising.
H. Bednarz, Magdalena Mortka, Gabriela Piotrowska et al.· Quality in Sport· 0 citations
Traditional treatments such as dietary fiber, probiotics, antispasmodics, laxatives, laxatives, prokinetics, antidepressants, antibiotics, and antihistamines are reviewed, emphasizing the limited and often inconsistent evidence supporting their use for pain relief and overall symptom improvement.
M. G. Puoti, A. Oorthuys, N. K. Vermeijden et al.· Drugs· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.